Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709)

References

• Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol. 2005; 23:2346–57.
   PubMed Web of Science ®Google Scholar
• Hakansson A, Gustafsson B, Krysander L, Hjelmqvist B, Rettrup B, Hakansson L. Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes. Br J Cancer. 2001; 85:1871–7.
   PubMed Web of Science ®Google Scholar
• Sensi M, Parmiani G. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol Today. 1995; 16:588–95.
   PubMedGoogle Scholar
• Dudley ME, Rosenberg SA. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer. 2003; 3:666–75.
   PubMed Web of Science ®Google Scholar
• Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci USA. 2002; 99:16168–73.
   PubMed Web of Science ®Google Scholar
• Kershaw MH, Westwood JA, Hwu P. Dual-specific T cells combine proliferation and antitumor activity. Nat Biotechnol. 2002; 20:1221–7.
   PubMed Web of Science ®Google Scholar
• Riviere I, Sadelain M, Brentjens RJ. Novel strategies for cancer therapy: the potential of genetically modified T lymphocytes. Curr Hematol Rep. 2004; 3:290–7.
   Google Scholar
• Clay TM, Custer MC, Sachs J, Hwu P, Rosenberg SA, Nishimura MI. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol. 1999; 163:507–13.
   PubMed Web of Science ®Google Scholar
• Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 2006; 314:126–9.
   PubMed Web of Science ®Google Scholar
• Duval L, Schmidt H, Kaltoft K, Fode K, Jensen JJ, Sorensen SM, et al. Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma. Clin Cancer Res. 2006; 12:1229–36.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999; 401:708–12.
   PubMed Web of Science ®Google Scholar
• McCutheon M, Wehner N, Wensky A, Kushner M, Doan S, Hsiao L, et al. A Sensitive ELISPOT to detect low-frequency human T lymphocytes. J. Immunol. Methods.. 1997; 210:149–66.
   Google Scholar
• thor Straten P, Becker JC, Zeuthen J, Guldberg P. T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis (DGGE): analyses of clonal T-cell responses in melanoma. Melanoma Methods and Protocols. Nicholoff B, Melanoma Methods and Protocols. Humana Press Inc., 2001; 339–351.
   Google Scholar
• Arden B, Clark SP, Kabelitz D, Mak TW. Human T-cell receptor variable gene segment families. Immunogenetics. 1995; 42:455–500.
   PubMedGoogle Scholar
• thor Straten P, Barfoed A, Seremet T, Saeterdal I, Zeuthen J, Guldberg P. Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE). Biotechniques. 1998; 25:244–50.
   Google Scholar
• Hadrup SR, Strindhall J, Kollgaard T, Seremet T, Johansson B, Pawelec G, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol. 2006; 176:2645–53.
   PubMed Web of Science ®Google Scholar
• thor Straten P, Dahl C, Schrama D, Pedersen LO, Andersen MH, Seremet T, et al. Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes. Cancer Immunol Immunother. 2006; 55:495–502.
   Google Scholar
• Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA. 1994; 91:3515–9.
   PubMed Web of Science ®Google Scholar
• Wang RF, Appella E, Kawakami Y, Kang X, Rosenberg SA. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med. 1996; 184:2207–16.
   PubMed Web of Science ®Google Scholar
• Andersen MH, Becker JC, thor Straten P. Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov. 2005; 4:399–409.
   Google Scholar
• Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Lienard D, Lejeune F, et al. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med. 1999; 190:705–15.
   PubMed Web of Science ®Google Scholar
• Valmori D, Dutoit V, Schnuriger V, Quiquerez AL, Pittet MJ, Guillaume P, et al. Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. J Immunol. 2002; 168:4231–40.
   Google Scholar
• Valmori D, Dutoit V, Lienard D, Lejeune F, Speiser D, Rimoldi D, et al. Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. J Immunol. 2000; 165:533–8.
   PubMed Web of Science ®Google Scholar
• Moss PA, Moots RJ, Rosenberg WM, Rowland-Jones SJ, Bodmer HC, McMichael AJ, et al. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA. 1991; 88:8987–90.
   PubMedGoogle Scholar
• Dietrich PY, Walker PR, Quiquerez AL, Perrin G, Dutoit V, Lienard D, et al. Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. Cancer Res. 2001; 61:2047–54.
   Google Scholar
• Speiser DE, Baumgaertner P, Barbey C, Rubio-Godoy V, Moulin A, Corthesy P, et al. A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination. J Immunol. 2006; 177:1338–48.
   PubMed Web of Science ®Google Scholar
• Mandruzzato S, Rossi E, Bernardi F, Tosello V, Macino B, Basso G, et al. Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient. J Immunol. 2002; 169:4017–24.
   PubMed Web of Science ®Google Scholar
• Trautmann L, Labarriere N, Jotereau F, Karanikas V, Gervois N, Connerotte T, et al. Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur J Immunol. 2002; 32:3181–90.
   PubMed Web of Science ®Google Scholar
• Schrama D, Andersen MH, Terheyden P, Schroder L, Pedersen LO, thor Straten P, et al. Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients. Cancer Res. 2001; 61:493–6.
   PubMed Web of Science ®Google Scholar
• Andersen MH, Gehl J, Reker S, Pedersen LO, Becker JC, Geertsen P, et al. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration. Semin Cancer Biol. 2003; 13:449–59.
   PubMed Web of Science ®Google Scholar
• De Vries IJ, Bernsen MR, van Geloof WL, Scharenborg NM, Lesterhuis WJ, Rombout PD, et al. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. Cancer Immunol Immunother. 2007; 56:1667–76.
   PubMed Web of Science ®Google Scholar
• Chothia C, Boswell DR, Lesk AM. The outline structure of the T-cell alpha beta receptor. EMBO J. 1988; 7:3745–55.
   PubMed Web of Science ®Google Scholar